Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8670721 | The Journal of Thoracic and Cardiovascular Surgery | 2018 | 34 Pages |
Abstract
In Ross patients who require reintervention on the PV homograft, both tPVR and sPVR provide low procedural mortality and comparable midterm outcome with no significant difference in mortality or PV reintervention. However, IE is more common following tPVR. A larger randomized study is needed to determine the role of each procedure in patient management.
Keywords
TPVRTranscatheter pulmonary valve replacementMACETTENYHAFACNew York Heart Associationinfective endocarditisTransthoracic echocardiographyReinterventionRight ventricularPulmonary valve replacementfractional area changepulmonary valveRoss procedureMajor adverse cardiac eventPVRconfidence intervalTAPSEOutcomehazard ratiotricuspid annular plane systolic excursion
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Khadija MD, Dania MD, PhD, Marie Annick DVM, PhD, Aysha MD, Talal MD, Mansour MD, Zohair MD, Bahaa M. MD,